Bausch Health and Salix Pharmaceuticals settled outstanding intellectual property claims against their drug Xifaxan from generic drugmaker Actavis Laboratories.
Bayer added a warning to its prescription-free stomach relief Iberogast drops after a patient died from the product.
The FDA awarded Motus GI’s Pure-Vu Slim Sleeve 510(k) clearance, expanding Motus’ reach to encompass the full range of gastrointestinal procedures.
Prescient Medicine Holdings and Metabiomics partnered to develop a microbiome diagnostic platform to diagnose gastrointestinal diseases including Crohn’s disease, ulcerative colitis and irritable bowel syndrome.
More articles on gastroenterology:
Prescient Medicine, Metabiomics developing CRC detecting test — 3 insights
GI leader to know: Dr. Jacob Karr of The Gastro Clinic
St. Luke’s Gastroenterology Associates adds Dr. Yonatan Hillman — 3 insights
